Cargando…

Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease

Detalles Bibliográficos
Autores principales:	Bolon, B, Carter, C, Daris, M, Morony, S, Campagnuolo, G, Feige, U, Sheng, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272734/ http://dx.doi.org/10.1186/ar371

Ejemplares similares

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
por: Bjerre, Mette
Publicado: (2013)

Treatment with OPG and cellular gene therapy with IL-4 decrease bone resorption-associated inflammation in collagen-induced arthritis
por: Saidenberg-Kermanac'h, N, et al.
Publicado: (2003)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

The role of RANK ligand/OPG system in bone erosions in rheumatoid arthritis
por: Geusens, Piet
Publicado: (2012)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
por: Eid, Riham, et al.
Publicado: (2023)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

TRAIL-induced rheumatoid arthritis fibroblast-like synoviocyte proliferation is inhibited by OPG
por: Morel, J, et al.
Publicado: (2004)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-Implantitis Susceptibility in a Chinese Han Population
por: Zhou, Jian, et al.
Publicado: (2016)

Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis
por: Lubberts, E, et al.
Publicado: (2004)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
por: Tariq, Saba, et al.
Publicado: (2022)

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis
por: Peng, Yuqin, et al.
Publicado: (2018)

Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
por: Wang, Yan, et al.
Publicado: (2011)

Protection of inflammation-related bone loss by OPG and TNF-α antibodies through distinct mechanisms in collagen-induced arthritis
por: Saidenberg-Kermanach, N, et al.
Publicado: (2004)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
por: Reid, Penny E, et al.
Publicado: (2009)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
por: Hou, Lele, et al.
Publicado: (2011)

Genetics of osteoarticular disorders, Florence, Italy, 22–23 February 2002
por: Falchetti, Alberto
Publicado: (2002)

The Spectrum of Pediatric Osteoarticular Infections: A Comparative Study
por: Alhinai, Zaid, et al.
Publicado: (2017)

The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis: Erratum
Publicado: (2019)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
por: Widschwendter, Martin, et al.
Publicado: (2015)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies
por: Stolina, Marina, et al.
Publicado: (2009)

Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis
por: Goswami, Sudeshna, et al.
Publicado: (2016)

Osteoarticular Tuberculosis
por: Cataño, Juan, et al.
Publicado: (2022)

246. Particularities of Non-axial Osteoarticular Tuberculosis Among Adults
por: Hammami, Fatma, et al.
Publicado: (2021)

Gene therapy of destructive arthritis in SCID mice
por: Sack, U, et al.
Publicado: (2003)

Variability in Management of Acute Osteoarticular Infections at a Children’s Hospital and Favorable Outcomes with Increasing Early Transition to Oral Therapy
por: Biary, Nora, et al.
Publicado: (2017)

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
por: Lane, Denis, et al.
Publicado: (2013)

Osteoprotegerin (OPG) Promotes Recruitment of Endothelial Progenitor Cells (EPCs) via CXCR4 Signaling Pathway to Improve Bone Defect Repair
por: Zhang, Rongfeng, et al.
Publicado: (2019)

The Impact of Angiotensin Converting Enzyme-2 (ACE-2) on Bone Remodeling Marker Osteoprotegerin (OPG) in Post-COVID-19 Iraqi Patients
por: AL-Azzawi, Islam S, et al.
Publicado: (2022)

Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling
por: Al-Nasrallah, Huda K., et al.
Publicado: (2022)

Epinephrine application via a conventional endotracheal airway and via the Combitube™ in esophageal position in an animal model
por: Kofler, J, et al.
Publicado: (1997)

Osteoarticular Infections Following Open or Penetrating Trauma in Children in the Era of Community-Acquired MRSA
por: McNeil, Jonathon, et al.
Publicado: (2017)

Testing an emerging animal model for use in the allergenicity assessment of food
por: Lefebvre, David E, et al.
Publicado: (2011)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_hk2n7b2i8v680o1hukuiolee4b